Clinical trial
Duloxetine in the Treatment of Melancholic Depression
NCT00191685 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191685 |
|---|---|
| Title | Duloxetine in the Treatment of Melancholic Depression |
| Official title | Duloxetine in the Treatment of Melancholic Depression: An 8-Week Open-Label Dose Study |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | duloxetine |
| Enrollment | 200 |
| Start date | May 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Jul 25, 2006 |
| Countries | Australia, Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: